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Both echocardiography and cardiac magnetic reso-
nance imaging (CMR) are currently recognized as
accurate and reliable means of evaluating cardiac
anatomy and ventricular function. Echocardiography
is still the mainstay of assessing left ventricular
function but over the past years considerable progress
has been made in the ﬁeld of CMR, providing accurate
evaluation of left ventricular function particularly in
patients with heart failure due to ischemic cardiomy-
opathy [1–11]. Stress ﬁrst-pass contrast-enhanced
myocardial perfusion CMR can be used to detect
subendocardial ischemia and recent studies have
demonstrated the high diagnostic accuracy of stress
myocardial perfusion CMR for detecting signiﬁcant
coronary artery disease [12–17]. Magnetic resonance
angiography (MRA) has been introduced as a method
that can provide visualization of all three major
coronary arteries, coronary anomalies, coronary
bypasses and the aorta within a single three-dimen-
sional acquisition [18–21]. CMR has become the
ﬁrst choice imaging modality in complex congenital
heart disease [22–26] and imaging great vessels
[27, 28].
Over the past years, contrast-enhanced CMR has
been used to visualize the transmural extent of
myocardial infarction with high spatial resolution
[29–34]. Infarcted myocardium appears hyperen-
hanced compared with normal myocardium when
imaged by a late enhancement CMR. The transmural
extent of delayed gadolinium enhancement predicts
functional outcome after interventional procedures
performed in patients with acute myocardial infarc-
tion and chronic ischemic heart disease [35–39].
In the current issue of the International Journal of
Cardiovascular Imaging, Wong et al. [40] reported
43 patients with ischemic cardiomyopathy (age
59 ± 9 years, mean LVEF 24 ± 8%) who underwent
cardiopulmonary exercise testing, echocardiography
and CMR. The purpose of the study was to examine
the relationship between noninvasive measurements
of ventricular-vascular coupling (VVC) with exercise
tolerance. Measurements of oxygen consumption,
carbon dioxide production, heart rate, minute venti-
lation, tidal volume, and respiratory rate were made
both at rest and during exercise. The authors com-
pared the value of VVC versus other traditional
determinants of exercise capacity in this population.
VVC was deﬁned non-invasively by the ratio of
ventricular systolic elastance (Ees) to arterial elas-
tance (Ea). It was clearly shown that both Ea and Ees
were markedly depressed at rest irrespective of age
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DOI 10.1007/s10554-009-9533-3and gender. There was an unfavorable rightward shift
of systolic-pressure–volume relationship implying a
reduced stroke efﬁciency and diminished cardiac
reserve during physiological stress. A higher VVC
was associated with higher LVEF and RVEF but
showed inverse relation to mitral E wave velocity.
VVC was independent of arterial stiffness and
diastolic dysfunction. The authors concluded that
ventricular-arterial coupling at rest may be a clini-
cally important parameter in predicting exercise
capacity in patients with advanced heart failure, and
may become an additional target for therapeutic
interventions.
This article is important for several reasons. First,
a multimodality imaging approach was used,
whereby echocardiography primarily provided
important diastolic function data. CMR allowed the
measurement of both volumetric parameters and
aortic distensibility. Based on the volume data Ees
and Ea could be measured as pertinent parameters of
intrinsic cardiovascular dynamicics. In previous
studies, the Leiden group represented by Baan en
Steendijk et al. already gained world-wide recogni-
tion using Ees and Ea measurements obtained with a
conductance catheter [41]. These measurements pro-
vide true and unique insights in myocardial contrac-
tility and ventricular dynamics in various cardiac
disease states such as hypertrophic cardiomyopathy,
ischemic cardiomyopathy, both before and after
cardiac surgery [42–44]. Assessing aortic distensibil-
ity with CMR has been shown a very reliable way of
assessing aortic stiffness in particular in patients with
Marfan’s disease [45–47]. Measuring aortic stiffness
might of course also be of interest in patients with
ischemic cardiomyopathy and it is interesting to
notice that the authors found a signiﬁcant correlation
between aortic distensibiltiy and maximum oxygen
consumption. In addition, patients with systolic heart
failure showed markedly reduced distensibility of the
proximal aorta. Lastly, all patients were subjected to
metabolic exercise testing which is rather unique for
a population with ischemic cardiomyopathy and
advanced heart failure, allowing the assessment of
oxygen uptake kinetics in these patients [48–50].
Although the clinical implication and integration of
this approach has to be awaited because of the
sophisticated methodology used, this study adds
unique physiological information on the ventricular
dynamics in patients with ischemic cardiomyopathy.
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